Research Article
Urinary Clusterin Is Upregulated in Nephropathia Epidemica
Table 3
Comparative analysis of kidney toxicity markers in NE, SLE, type 2 diabetes, CKI, and gout.
| | Patient group | Calbindin | Clusterin | GST-π | IL-18 | KIM-1 | CCL2 |
| | Control | 66459.1 ± 25284.1 | 19785.8 ± 6384.3 | 33688.5 ± 10201.6 | 5.8 ± 0.6 | 80.8 ± 10.9 | 70.6 ± 16.4 | | NE | 85876.1 ± 2689.2
| 174341.9 ± 72065
| 47344.4 ± 24993 | 32.7 ± 8.6
| 813.2 ± 205.2
| 442.7 ± 100.6
| | Gout | 22727.9 ± 4971.2 | 23793.4 ± 12298.9 | 3511.8 ± 646.9
| 10.7 ± 2.1 | 236.5 ± 77.8
| 144.3 ± 49.1 | | Type 2 diabetes | 34102.5 ± 10407.8 | 51272.1 ± 22931.1 | 14008.6 ± 3865.4 | 10.8 ± 2.9 | 330.5 ± 118.4
| 412.5 ± 145.1
| | CKI | 28778.8 ± 10907.8 | 49218.5 ± 27304.5 | 14846.8 ± 3772.1 | 14.6 ± 4.4 | 414.4 ± 186.9
| 526.9 ± 409.4
| | SLE | 71437.9 ± 42320.5 | 66160.7 ± 27984.5
| 27211.1 ± 6190.7 | 636.3 ± 622.3
| 526.5 ± 308.9
| 336.7 ± 148.4
|
|
|
